SPDR S&P Biotech (NYSEARCA:XBI) was the target of unusually large options trading activity on Thursday. Stock investors bought 35,792 put options on the company. This is an increase of 347% compared to the typical volume of 8,011 put options.

Shares of SPDR S&P Biotech (XBI) opened at 75.77 on Friday. The stock has a 50 day moving average of $78.49 and a 200 day moving average of $71.56. SPDR S&P Biotech has a 12-month low of $53.15 and a 12-month high of $82.38.

Several large investors have recently made changes to their positions in the stock. Quantitative Investment Management LLC raised its position in shares of SPDR S&P Biotech by 642.3% in the second quarter. Quantitative Investment Management LLC now owns 1,451,998 shares of the exchange traded fund’s stock valued at $112,065,000 after buying an additional 1,256,398 shares during the period. FMR LLC raised its position in shares of SPDR S&P Biotech by 6.2% in the second quarter. FMR LLC now owns 191,702 shares of the exchange traded fund’s stock valued at $14,796,000 after buying an additional 11,241 shares during the period. Papp L Roy & Associates raised its position in shares of SPDR S&P Biotech by 3.1% in the second quarter. Papp L Roy & Associates now owns 187,538 shares of the exchange traded fund’s stock valued at $14,474,000 after buying an additional 5,648 shares during the period. Main Management LLC raised its position in shares of SPDR S&P Biotech by 0.7% in the second quarter. Main Management LLC now owns 146,360 shares of the exchange traded fund’s stock valued at $11,296,000 after buying an additional 978 shares during the period. Finally, Polaris Greystone Financial Group LLC raised its position in shares of SPDR S&P Biotech by 1.4% in the second quarter. Polaris Greystone Financial Group LLC now owns 132,336 shares of the exchange traded fund’s stock valued at $10,214,000 after buying an additional 1,866 shares during the period.

ILLEGAL ACTIVITY NOTICE: “Traders Purchase High Volume of Put Options on SPDR S&P Biotech (XBI)” was published by Daily Political and is the sole property of of Daily Political. If you are viewing this report on another site, it was stolen and reposted in violation of US and international trademark and copyright legislation. The legal version of this report can be viewed at https://www.dailypolitical.com/2017/08/12/traders-purchase-high-volume-of-put-options-on-spdr-sp-biotech-xbi.html.

About SPDR S&P Biotech

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.

Receive News & Ratings for SPDR S&P Biotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech and related companies with MarketBeat.com's FREE daily email newsletter.